1.Discuss whether you might be a candidate for a bone mineral density test.
探讨一下你是否应该做一个骨骼矿物质密度检查。
2.Bone mineral density is considered to be the standard measure for the diagnosis of osteoporosis and the assessment of fracture risk.
骨密度被认为是对骨质疏松症的诊断和骨折风险评估的标准措施。
3.Zoledronic acid was also associated with a significant improvement in bone mineral density and bone metabolism markers.
唑来膦酸注射也伴随着骨矿物质密度和骨新陈代谢标志物的显著改善。
4.Bone mineral density (BMD) is widely used to measure bone loss and assess effectiveness of treatments for osteoporosis by WHO.
骨矿密度（BMD）是诊断骨量减少（低骨量，骨质疏松），评价骨丢失率和疗效的重要客观指标。
5.AIM: To explore the relationship between the changes of bone mineral density (BMD) and bone marrow angiogenesis in ovariectomized rats.
目的：探讨去卵巢大鼠骨密度变化与骨髓组织血管生成的关系。
6.Different movements have different influences on bone mineral density. High impact training surpasses low intensity of endurance training.
不同的运动形式对骨密度的影响各异，高冲击性的训练优于低强度的耐力训练。
7.Estrogen depletion by menopause decreases bone mineral density and the replacement of this hormone restores the bone loss.
绝经期雌激素降低消耗的骨密度和更换这一激素恢复骨丢失。
8.Age, hypogonadism are one of the strong risk factors for low bone mineral density.
年龄，性腺机能减退的一个强有力的危险因素，低骨密度。
9.postmenopausal osteoporosis; Tuina treatment; bone mineral density; senile symptoms.
绝经后骨质疏松症；推拿；骨密度；衰老症状。
10.no matter the subjects with normal bone mineral density or not, more than half of them didn't have the habit of regular exercise.
不论骨质密度正常或不良者，半数以上皆未有规律运动之习惯，且多从事低负荷及无负荷之运动；